Skip to main content

. 1983 Feb 26;286(6366):695–697. doi: 10.1136/bmj.286.6366.695

New drugs. H2 receptor antagonists--cimetidine and ranitidine.

J Feely, K G Wormsley

PMCID: PMC1547117 PMID: 6130817

695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
Brogden R. N., Carmine A. A., Heel R. C., Speight T. M., Avery G. S. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs. 1982 Oct;24(4):267–303. doi: 10.2165/00003495-198224040-00002. [DOI] [PubMed] [Google Scholar]
Freston J. W. Cimetidine. I. Developments, pharmacology, and efficacy. Ann Intern Med. 1982 Oct;97(4):573–580. doi: 10.7326/0003-4819-97-4-573. [DOI] [PubMed] [Google Scholar]
Henry D. A., Langman M. J. Adverse effects of anti-ulcer drugs. Drugs. 1981 Jun;21(6):444–459. doi: 10.2165/00003495-198121060-00004. [DOI] [PubMed] [Google Scholar]
Venables C. W., Wheldon E. J., Cranage J. D. Adverse effects of gastric surgery for peptic ulceration. J R Coll Physicians Lond. 1980 Jul;14(3):173–177. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES